WO2008093767A1 - ベンジルアミン誘導体またはその薬学的に許容される酸付加塩、およびその医薬用途 - Google Patents
ベンジルアミン誘導体またはその薬学的に許容される酸付加塩、およびその医薬用途 Download PDFInfo
- Publication number
- WO2008093767A1 WO2008093767A1 PCT/JP2008/051479 JP2008051479W WO2008093767A1 WO 2008093767 A1 WO2008093767 A1 WO 2008093767A1 JP 2008051479 W JP2008051479 W JP 2008051479W WO 2008093767 A1 WO2008093767 A1 WO 2008093767A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutically acceptable
- acid addition
- addition salt
- acceptable acid
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008800036203A CN101595088B (zh) | 2007-01-31 | 2008-01-31 | 苯甲胺衍生物或其药学上允许的酸加成盐及其医药用途 |
AU2008210637A AU2008210637B2 (en) | 2007-01-31 | 2008-01-31 | Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
DK08704230.5T DK2119700T3 (da) | 2007-01-31 | 2008-01-31 | Benzylaminderivat eller farmaceutisk acceptabelt syreadditionssalt heraf og anvendelse heraf til medicinske formål |
CA2677061A CA2677061C (en) | 2007-01-31 | 2008-01-31 | Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
KR1020097013383A KR101479048B1 (ko) | 2007-01-31 | 2008-01-31 | 벤질아민 유도체 또는 그 약학적으로 허용되는 산부가염, 및 그 의약 용도 |
EP08704230A EP2119700B1 (en) | 2007-01-31 | 2008-01-31 | Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
US12/525,364 US8148427B2 (en) | 2007-01-31 | 2008-01-31 | Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
JP2008556166A JP4720909B2 (ja) | 2007-01-31 | 2008-01-31 | ベンジルアミン誘導体またはその薬学的に許容される酸付加塩、およびその医薬用途 |
ES08704230T ES2387586T3 (es) | 2007-01-31 | 2008-01-31 | Derivado de bencilamina o sal de adición de ácido del mismo farmacéuticamente aceptable y utilización del mismo para fines médicos |
PL08704230T PL2119700T3 (pl) | 2007-01-31 | 2008-01-31 | Pochodna benzyloaminy lub jej farmaceutycznie dopuszczalna sól addycyjna z kwasem oraz ich zastosowanie do celów medycznych |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-020582 | 2007-01-31 | ||
JP2007020582 | 2007-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008093767A1 true WO2008093767A1 (ja) | 2008-08-07 |
Family
ID=39674074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/051479 WO2008093767A1 (ja) | 2007-01-31 | 2008-01-31 | ベンジルアミン誘導体またはその薬学的に許容される酸付加塩、およびその医薬用途 |
Country Status (12)
Country | Link |
---|---|
US (1) | US8148427B2 (ja) |
EP (1) | EP2119700B1 (ja) |
JP (1) | JP4720909B2 (ja) |
KR (1) | KR101479048B1 (ja) |
CN (1) | CN101595088B (ja) |
AU (1) | AU2008210637B2 (ja) |
CA (1) | CA2677061C (ja) |
DK (1) | DK2119700T3 (ja) |
ES (1) | ES2387586T3 (ja) |
PL (1) | PL2119700T3 (ja) |
PT (1) | PT2119700E (ja) |
WO (1) | WO2008093767A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010013798A1 (ja) | 2008-07-31 | 2010-02-04 | 東レ株式会社 | ベンジルアミン誘導体又はその薬学的に許容される酸付加塩を含有する糖尿病、肥満症、脂質異常症若しくはメタボリックシンドロームの治療剤又は予防剤 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3341584A (en) | 1962-01-24 | 1967-09-12 | Mead Johnson & Co | Anilides |
JPH07206806A (ja) | 1993-12-21 | 1995-08-08 | Bristol Myers Squibb Co | β3アゴニストとして有用なカテコールアミン代用物 |
WO1999020607A1 (fr) | 1997-10-17 | 1999-04-29 | Yamanouchi Pharmaceutical Co., Ltd. | Derives amides ou sels desdits derives |
WO2000059885A1 (fr) * | 1999-04-01 | 2000-10-12 | Asahi Kasei Kabushiki Kaisha | Procede de preparation de derives d'alcools amines tricycliques avec des azides |
JP2002512639A (ja) | 1998-04-06 | 2002-04-23 | 藤沢薬品工業株式会社 | プロパノールアミン誘導体 |
US20020068751A1 (en) * | 2000-07-17 | 2002-06-06 | American Home Products Corporation | Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists |
WO2005040093A1 (ja) | 2003-10-24 | 2005-05-06 | Kissei Pharmaceutical Co., Ltd. | アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6436914B1 (en) * | 1998-06-30 | 2002-08-20 | Bristol-Myers Squibb Company | 2-hydroxy-3—(4-hydroxy-3-sulfonamidophenyl)—propylamines useful as beta 3 adrenergic agonists |
PE20040950A1 (es) * | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
-
2008
- 2008-01-31 JP JP2008556166A patent/JP4720909B2/ja active Active
- 2008-01-31 DK DK08704230.5T patent/DK2119700T3/da active
- 2008-01-31 CA CA2677061A patent/CA2677061C/en not_active Expired - Fee Related
- 2008-01-31 PL PL08704230T patent/PL2119700T3/pl unknown
- 2008-01-31 PT PT08704230T patent/PT2119700E/pt unknown
- 2008-01-31 CN CN2008800036203A patent/CN101595088B/zh not_active Expired - Fee Related
- 2008-01-31 US US12/525,364 patent/US8148427B2/en not_active Expired - Fee Related
- 2008-01-31 ES ES08704230T patent/ES2387586T3/es active Active
- 2008-01-31 AU AU2008210637A patent/AU2008210637B2/en not_active Ceased
- 2008-01-31 KR KR1020097013383A patent/KR101479048B1/ko not_active IP Right Cessation
- 2008-01-31 WO PCT/JP2008/051479 patent/WO2008093767A1/ja active Application Filing
- 2008-01-31 EP EP08704230A patent/EP2119700B1/en not_active Not-in-force
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3341584A (en) | 1962-01-24 | 1967-09-12 | Mead Johnson & Co | Anilides |
JPH07206806A (ja) | 1993-12-21 | 1995-08-08 | Bristol Myers Squibb Co | β3アゴニストとして有用なカテコールアミン代用物 |
WO1999020607A1 (fr) | 1997-10-17 | 1999-04-29 | Yamanouchi Pharmaceutical Co., Ltd. | Derives amides ou sels desdits derives |
JP2002512639A (ja) | 1998-04-06 | 2002-04-23 | 藤沢薬品工業株式会社 | プロパノールアミン誘導体 |
WO2000059885A1 (fr) * | 1999-04-01 | 2000-10-12 | Asahi Kasei Kabushiki Kaisha | Procede de preparation de derives d'alcools amines tricycliques avec des azides |
US20020068751A1 (en) * | 2000-07-17 | 2002-06-06 | American Home Products Corporation | Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists |
WO2005040093A1 (ja) | 2003-10-24 | 2005-05-06 | Kissei Pharmaceutical Co., Ltd. | アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途 |
Non-Patent Citations (12)
Title |
---|
"Experimental Methods in Pharmacology", KYODO ISHO SHUPPAN CO., LTD, pages: 168 |
"Experimental Methods in Pharmacology", KYODO ISHO SHUPPAN CO., LTD., pages: 166 |
"Experimental Methods in Pharmacology", KYODO ISHO SHUPPAN CO., LTD., pages: 168 |
"Fieser and Fieser's Reagent for Organic Synthesis", WILEY & SONS |
"Organic Reaction", WILEY & SONS |
J. PHARMACOL. EXP. THER., vol. 271, 1994, pages 1253 |
J. PHARMACOL. EXP. THER., vol. 293, 2000, pages 939 |
J.UROLOGY, vol. 165, 2001, pages 240 |
JPN. J. PHARMACOL., vol. 87, 2001, pages 27 |
NAUNYN-SCHMIEDEBERG'S ARCH. PHARMACOL., vol. 369, 2004, pages 151 |
See also references of EP2119700A4 * |
SUM F.-W. ET AL.: "Cyclic amine sulfonamides as linkers in the design and synthesis of novel human beta3 adrenergic receptor agonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 13, no. 13, 2003, pages 2191 - 2194, XP002282659 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010013798A1 (ja) | 2008-07-31 | 2010-02-04 | 東レ株式会社 | ベンジルアミン誘導体又はその薬学的に許容される酸付加塩を含有する糖尿病、肥満症、脂質異常症若しくはメタボリックシンドロームの治療剤又は予防剤 |
EP2311447A4 (en) * | 2008-07-31 | 2012-04-18 | Toray Industries | THERAPEUTIC OR PROPHYLACTIC AGENT FOR DIABETES, ADIPOSITAS, DYSLIPIDEMIA OR METABOLIC SYNDROME WITH A BENZYLAMINE DERIVATIVE OR A PHARMACEUTIC ACCEPTIC ACID SALT OTHER THEREOF |
US8198330B2 (en) | 2008-07-31 | 2012-06-12 | Toray Industries, Inc. | Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof |
JP5597992B2 (ja) * | 2008-07-31 | 2014-10-01 | 東レ株式会社 | ベンジルアミン誘導体又はその薬学的に許容される酸付加塩を含有する糖尿病、肥満症、脂質異常症若しくはメタボリックシンドロームの治療剤又は予防剤 |
Also Published As
Publication number | Publication date |
---|---|
CA2677061C (en) | 2014-07-29 |
JPWO2008093767A1 (ja) | 2010-05-20 |
EP2119700B1 (en) | 2012-08-01 |
US20100099769A1 (en) | 2010-04-22 |
EP2119700A1 (en) | 2009-11-18 |
DK2119700T3 (da) | 2012-10-22 |
US8148427B2 (en) | 2012-04-03 |
AU2008210637B2 (en) | 2012-08-16 |
CN101595088B (zh) | 2013-06-19 |
PT2119700E (pt) | 2012-10-02 |
ES2387586T3 (es) | 2012-09-26 |
KR20090104815A (ko) | 2009-10-06 |
CA2677061A1 (en) | 2008-08-07 |
EP2119700A4 (en) | 2011-06-08 |
CN101595088A (zh) | 2009-12-02 |
AU2008210637A1 (en) | 2008-08-07 |
JP4720909B2 (ja) | 2011-07-13 |
KR101479048B1 (ko) | 2015-01-05 |
PL2119700T3 (pl) | 2013-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010088000A3 (en) | Antifibrotic compounds and uses thereof | |
WO2010084115A3 (en) | Antiviral agents | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
WO2006067165A3 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
WO2008075068A3 (en) | Acylaminopyrazoles as fgfr inhibitors | |
WO2009066152A3 (en) | Haloallylamine inhibitors of ssao/vap-1 and uses therefor | |
WO2009109618A3 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 | |
MX2011012122A (es) | Derivados de tiofeno. | |
WO2010136474A3 (en) | Substituted aminobutyric derivatives as neprilysin inhibitors | |
WO2005117890A3 (en) | Thienopyrimidines and thiazolopyrimidines for use in medicine | |
WO2007087395A3 (en) | UNSATURATED mTOR INHIBITORS | |
WO2009071480A3 (en) | Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors | |
WO2011058474A8 (en) | N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors | |
WO2009109616A8 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 | |
WO2007087204A3 (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia | |
WO2007057221A3 (en) | Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases | |
WO2007024843A3 (en) | Pyrimidinyl-pyrazole inhibitors of aurora kinases | |
WO2009041663A1 (ja) | 皮膚疾患の予防及び/または治療剤 | |
WO2008023258A8 (en) | Piperidine derivatives | |
EP2196206B8 (en) | Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient | |
WO2009109654A8 (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1 | |
WO2010107807A3 (en) | Compounds for treating inflammation and pain | |
WO2009038412A3 (en) | Beta-secretase inhibiting compounds | |
WO2010121675A3 (en) | Thiazolyl-benzimidazoles | |
WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880003620.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08704230 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097013383 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2008556166 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2677061 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12525364 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008210637 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2847/KOLNP/2009 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2008210637 Country of ref document: AU Date of ref document: 20080131 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008704230 Country of ref document: EP |